Response to Yates and Halliday Regarding Cytomegalovirus (CMV) DNAemia and Time to Death in a Randomized Trial of Preemptive Therapy Versus Antiviral Prophylaxis in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients
Clinical Infectious Diseases · 2024
DOI: 10.1093/cid/ciae005 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Lakshin Kumar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Liver Transplantation, Antiviral Agents, Cytomegalovirus. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
- Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Department of Medicine, VA Pittsburgh Healthcare System and University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Lakshin Kumar, Sayan Dasgupta, Cristina Murray-Krezan, Nina Singh, Robert M Rakita, Cynthia E Fisher, Ajit P Limaye
Förderung
- NHLBI NIH HHS
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- NIH HHS
- National Institutes of Health
Zitieren
APA
Kumar, L., Dasgupta, S., Murray-Krezan, C., Singh, N., Rakita, R. M., Fisher, C. E., & Limaye, A. P. (2024). Response to Yates and Halliday Regarding Cytomegalovirus (CMV) DNAemia and Time to Death in a Randomized Trial of Preemptive Therapy Versus Antiviral Prophylaxis in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae005
Vancouver
Kumar L, Dasgupta S, Murray-Krezan C, Singh N, Rakita RM, Fisher CE, et al. Response to Yates and Halliday Regarding Cytomegalovirus (CMV) DNAemia and Time to Death in a Randomized Trial of Preemptive Therapy Versus Antiviral Prophylaxis in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciae005
BibTeX
@article{Kumar2024,
author = {Kumar, Lakshin and Dasgupta, Sayan and Murray-Krezan, Cristina and Singh, Nina and Rakita, Robert M and Fisher, Cynthia E and Limaye, Ajit P},
title = {Response to Yates and Halliday Regarding Cytomegalovirus (CMV) DNAemia and Time to Death in a Randomized Trial of Preemptive Therapy Versus Antiviral Prophylaxis in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients},
journal = {Clinical Infectious Diseases},
year = {2024},
doi = {10.1093/cid/ciae005}
}
EUVIMED